|
🐜
|
Interferon‐β mediates stromal cell rescue of T cells from apoptosis
9 auth.
D. Pilling,
A. Akbar,
J. Girdlestone,
C. Orteu,
N. Borthwick,
N. Amft,
...
D. Scheel-Toellner,
C. Buckley,
M. Salmon
|
7 |
1999 |
7
🐜
|
|
🐜
|
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
44 auth.
R. Knobler,
P. Moinzadeh,
N. Hunzelmann,
A. Kreuter,
A. Cozzio,
L. Mouthon,
M. Cutolo,
F. Rongioletti,
C. Denton,
L. Rudnicka,
L. A. Frasin,
V. Smith,
A. Gabrielli,
E. Aberer,
M. Bagot,
...
G. Bali,
J. Bouaziz,
A. Olesen,
I. Foeldvari,
C. Francès,
A. Jalili,
U. Just,
V. Kähäri,
S. Kárpáti,
K. Kofoed,
D. Krasowska,
M. Olszewska,
C. Orteu,
J. Panelius,
Andrea Parodi,
A. Petit,
P. Quaglino,
A. Ranki,
J. M. Schmidt,
J. Seneschal,
A. Skrok,
M. Sticherling,
C. Sunderkötter,
Alain Taïeb,
A. Tanew,
P. Wolf,
M. Worm,
N. Wutte,
T. Krieg
|
7 |
2017 |
7
🐜
|
|
🦁
|
Fabry disease and the skin: data from FOS, the Fabry outcome survey
11 auth.
C. Orteu,
T. Jansen,
O. Lidove,
R. Jaussaud,
D. Hughes,
Guillem Pintos-Morell,
...
U. Ramaswami,
R. Parini,
G. Sunder-Plassman,
M. Beck,
A. Mehta
|
7 |
2007 |
7
🦁
|
|
🐜
|
Telomere Erosion in Memory T Cells Induced by Telomerase Inhibition at the Site of Antigenic Challenge In Vivo
13 auth.
J. R. Reed,
M. Vukmanovic‐Stejic,
J. Fletcher,
M. Soares,
J. E. Cook,
C. Orteu,
Sarah E. Jackson,
K. Birch,
G. Foster,
M. Salmon,
...
P. Beverley,
M. Rustin,
A. Akbar
|
7 |
2004 |
7
🐜
|
|
🐜
|
A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse.
10 auth.
B. O'Brien,
X. Geng,
C. Orteu,
Yongqian Huang,
M. Ghoreishi,
Yiqun Zhang,
...
J. Bush,
Gang Li,
D. Finegood,
J. Dutz
|
6 |
2006 |
6
🐜
|
|
🐜
|
Interferon-beta mediates stromal cell rescue of T cells from apoptosis.
9 auth.
D. Pilling,
A. Akbar,
J. Girdlestone,
C. Orteu,
N. Borthwick,
N. Amft,
...
D. Scheel-Toellner,
C. Buckley,
M. Salmon
|
6 |
1999 |
6
🐜
|
|
🐜
|
European dermatology forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis
44 auth.
R. Knobler,
P. Moinzadeh,
N. Hunzelmann,
A. Kreuter,
A. Cozzio,
L. Mouthon,
M. Cutolo,
F. Rongioletti,
C. Denton,
L. Rudnicka,
L. A. Frasin,
V. Smith,
A. Gabrielli,
E. Aberer,
M. Bagot,
...
G. Bali,
J. Bouaziz,
A. Braae Olesen,
I. Foeldvari,
C. Francès,
A. Jalili,
U. Just,
V. Kähäri,
S. Kárpáti,
K. Kofoed,
D. Krasowska,
M. Olszewska,
C. Orteu,
J. Panelius,
A. Parodi,
A. Petit,
P. Quaglino,
A. Ranki,
J. S. Sánchez Schmidt,
J. Seneschal,
A. Skrok,
M. Sticherling,
C. Sunderkötter,
A. Taieb,
A. Tanew,
P. Wolf,
M. Worm,
N. Wutte,
T. Krieg
|
6 |
2017 |
6
🐜
|
|
🦁
|
The role of apoptosis in the resolution of T cell-mediated cutaneous inflammation.
C. Orteu,
Leonard W. Poulter,
M. Rustin,
C. Sabin,
M. Salmon,
A. N. Akbar
|
6 |
1998 |
6
🦁
|
|
🐬
|
Predicting relapse after transsphenoidal surgery for Cushing's disease.
G. Toms,
M. McCarthy,
M. Niven,
C. Orteu,
T. King,
J. Monson
|
6 |
1993 |
6
🐬
|
|
🐜
|
Optimization of epicutaneous immunization for the induction of CTL.
7 auth.
R. Kahlon,
Yuxiang Hu,
C. Orteu,
A. Kifayet,
J. Trudeau,
R. Tan,
...
J. Dutz
|
6 |
2003 |
6
🐜
|
